| Attribute |
Value |
References |
| Symbol |
SLC17A1 |
|
| Name |
Solute Carrier Family 17 Member 1 |
|
| Alternate Name |
VGLUT1 (Vesicular Glutamate Transporter 1) |
|
| Chromosome |
6p21.3 |
|
| NCBI Gene ID |
6568 |
|
| UniProt ID |
O15230 |
|
| OMIM |
182002 |
|
| Ensembl ID |
ENSG00000139508 |
|
SLC17A1 encodes VGLUT1 (Vesicular Glutamate Transporter 1), the primary transporter responsible for packaging the excitatory neurotransmitter glutamate into synaptic vesicles. VGLUT1 is a critical marker for glutamatergic neurons and is essential for excitatory neurotransmission in the central nervous system. Dysregulation of VGLUT1 function has been implicated in various neurological and neurodegenerative disorders.
VGLUT1 is a member of the major facilitator superfamily (MFS) of transporters. It functions as an electrogenic antiporter that transports glutamate into synaptic vesicles in exchange for protons (H+) that are pumped into the vesicle by the V-ATPase.
The transport cycle:
- Vesicle acidification: V-ATPase pumps H+ into the vesicle, creating a proton gradient
- Glutamate loading: VGLUT1 uses the H+ gradient to drive glutamate uptake
- Vesicle filling: Glutamate accumulates to concentrations >100 mM
- Synaptic release: Vesicle fusion with the presynaptic membrane releases glutamate into the synaptic cleft
Glutamate is the major excitatory neurotransmitter in the mammalian brain, acting on:
- NMDA receptors: Ionotropic, high conductance, Ca²⁺-permeable
- AMPA receptors: Ionotropic, fast excitatory responses
- Kainate receptors: Ionotropic, modulatory effects
- mGluRs: Metabolotropic, G-protein coupled
VGLUT1 expression defines glutamatergic neurons and is essential for:
- Synaptic vesicle filling
- Quantal size determination
- Excitatory synaptic transmission
- Synaptic plasticity (LTP and LTD)
VGLUT1 exhibits region-specific expression in the brain:
High Expression:
Low/No Expression:
- Brainstem
- Spinal cord (where VGLUT2 dominates)
This pattern defines the major glutamatergic pathways in the forebrain.
Glutamate excitotoxicity is a well-established mechanism in AD pathogenesis:
- Excessive glutamate release: Impaired glutamate clearance leads to overactivation of NMDA receptors
- Calcium dysregulation: NMDA receptor overactivation causes excessive Ca²⁺ influx
- Oxidative stress: Ca²⁺ overload triggers mitochondrial dysfunction and ROS generation
- Synaptic loss: Glutamate-induced toxicity contributes to synaptic degeneration
VGLUT1 dysfunction may contribute to:
- Altered glutamate packaging in vesicles
- Dysregulated excitatory neurotransmission
- Impaired synaptic plasticity
Excitotoxicity also plays a role in PD:
- Substantia nigra vulnerability: Dopaminergic neurons are particularly susceptible to excitotoxic damage
- Glutamate transporter alterations: Changes in VGLUT and EAAT transporters
- Mitochondrial dysfunction: Excitotoxicity and mitochondrial failure create a vicious cycle
- Alpha-synuclein interaction: May affect glutamate transporter function
VGLUT2 (SLC17A6) rather than VGLUT1 is more implicated in PD, but system-wide glutamate dysregulation affects multiple pathways.
- VGLUT1 expression is altered in motor neurons in ALS
- Glutamate excitotoxicity is a key mechanism in motor neuron death
- Riluzole, an anti-glutamatergic drug, is an ALS treatment
- VGLUT1 dysregulation contributes to hyperexcitability
- Altered vesicular glutamate filling affects seizure threshold
¶ Schizophrenia and Psychiatric Disorders
- VGLUT1 expression changes in prefrontal cortex
- May contribute to glutamatergic dysfunction in psychosis
- VGLUT1 genetic variants associated with ASD risk
- Altered excitatory/inhibitory balance
VGLUT1 operates as a proton-coupled antiporter:
- Stoichiometry: ~1 glutamate : 1 H+ (electrogenic)
- Affinity: Low micromolar Km for glutamate
- Capacity: Can accumulate glutamate to >100 mM
- Turnover rate: ~10-100 cycles/second
VGLUT1 function is regulated by:
- Phosphorylation: Kinase pathways modulate activity
- Trafficking: Vesicle cycling affects availability
- Protein interactions: SV2, synaptophysin, other SV proteins
- Activity-dependent regulation: Chronic activity changes expression
flowchart TD
A["Glutamate Synthesis<br/>from Glutamine"] --> B["VGLUT1<br/>Vesicular Loading"]
B --> C["Synaptic Vesicle<br/>Pool"]
C --> D["Ca²⁺-triggered<br/>Fusion"]
D --> E["Glutamate Release<br/>to Synaptic Cleft"]
E --> F["Receptor Activation<br/>NMDA/AMPA/mGluR"]
F --> G["Signal Termination<br/>EAAT Reuptake"]
G --> B
flowchart TD
A["SLC17A1 Gene<br/>6p21.3"] --> B["VGLUT1 Protein<br/>Synaptic Vesicle Membrane"]
B --> C["Glutamate<br/>Packaging"]
C --> D["Vesicular H⁺ Gradient<br/>V-ATPase"]
D --> E["Excitatory<br/>Neurotransmission"]
E --> F["Synaptic Cleft<br/>Glutamate Release"]
F --> G["Ionotropic Receptors"]
G --> H["NMDA Receptor<br/>Ca²⁺ Influx"]
G --> I["AMPA Receptor<br/>Depolarization"]
F --> J["Metabotropic Receptors"]
J --> K["mGluR Signaling"]
H --> L["Synaptic Plasticity"]
I --> L
L --> M["Learning & Memory"]
H --> N["Excitotoxicity<br/>Pathology"]
I --> N
N --> O["Neurodegeneration<br/>AD/PD/ALS"]
- NMDA receptor antagonists: Memantine (approved for AD)
- AMPA receptor modulators: Perampanel and related compounds
- mGluR modulators: Group I and II mGluR antagonists
- VGLUT1 enhancers: Could enhance glutamatergic transmission in hypofunction states
- VGLUT1 inhibitors: Potential for reducing excitotoxicity (though non-specific)
- Narrow therapeutic window for glutamatergic drugs
- Essential nature of glutamate signaling
- Regional specificity of dysfunction
-
VGLUT1 as a marker: VGLUT1 expression definitively identifies glutamatergic neurons.
-
Excitotoxicity mechanism: Excessive glutamate causes pathological Ca²⁺ influx and cell death.
-
Synaptic plasticity: VGLUT1 function is essential for LTP and learning.
-
Disease relevance: VGLUT1 dysregulation contributes to multiple neurological disorders.